Privia Health Group, Inc.
PRVA· Nasdaq
Released Nov 7, 2024, before the open
10-Q filed Nov 7, 2024, 38 days after period end · 0001759655-24-000131
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $437.92M | $417.28M | $342.90M | $251.52M |
| Net Income | $3.54M | $5.64M | $1.62M | -$9.12M |
| EPS Diluted |
Privia Health Group, Inc. · CIK 1759655 · Engraved from SEC EDGAR
| $0.03 |
| $0.05 |
| $0.01 |
| -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.